PROTALIX BIOTHERAPEUTICS INC - COM (PLX)

CUSIP: 74365A101

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM
Total 13F shares
11,223,469
Share change
-122,664
Total reported value
$3,465,421
Put/Call ratio
155%
Price per share
$0.31
Number of holders
28
Value change
-$307,773
Number of buys
8
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 74365A101?
CUSIP 74365A101 identifies PLX - PROTALIX BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTALIX BIOTHERAPEUTICS INC - COM (PLX) as of Q4 2018

As of 31 Dec 2018, PROTALIX BIOTHERAPEUTICS INC - COM (PLX) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,223,469 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, Fosun International Ltd, Opaleye Management Inc., CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, SG Americas Securities, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, UBS Group AG, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MEITAV DASH INVESTMENTS LTD, and Sectoral Asset Management Inc. This page lists 28 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.